Daniel Silverman
Clinical Professor, Department of Molecular and Medical Pharmacology · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · · ·
History
Research
A tabulated summary of the FDG PET literature
Review · Journal of Nuclear Medicine · 2001 · 677 citations
JAMA · 2001 · First of 24 authors · Corresponding · 650 citations
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
Proceedings of the National Academy of Sciences of the United States of America · 2000 · 594 citations
42 papers
19 papers
- CG
13 papers
11 papers
- CS
10 papers
- CH
8 papers
7 papers · 6 as a fellow
- CE
7 papers
Grants
- 2011–2014
Acute and Long-Term Effects of Chemotherapy on Regional Cerebral Metabolism
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $423.5K · University of California Los Angeles
- 2002–2005
Evaluation of Presynaptic Calcium Channels In Vivo
National Institute of Mental Health · R21
Contact PI · $305.1K · University of California Los Angeles
Clinical trials
- 2018–2020
Principal investigator · Withdrawn · Early phase 1
University of California, Los Angeles
- 2018–2022
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
Principal investigator · Withdrawn · Phase 3
University of California, Los Angeles
- 2017–2022
Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year
Principal investigator · Completed · Phase 2
University of California, Los Angeles
- 2012–2014
Impact of Grape Consumption on Brain Metabolism and Cognitive Function
Principal investigator · Completed · Phase 1
University of California, Los Angeles